Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sophie Duranton"'
Autor:
Astrid Prioul, Dorine Fournier, Cécile Lefeuvre, Sophie Duranton, Pascale Olivier, Emeline Blanc, Laure Peyro-Saint-Paul, Sophie Ruault, Aurélie Jamet, Catherine Mouchel
Publikováno v:
Therapies
Therapies, 2023, ⟨10.1016/j.therap.2023.02.008⟩
Therapies, 2023, ⟨10.1016/j.therap.2023.02.008⟩
International audience; INTRODUCTION: The evaluation of clinical trial (CT) safety is the main task of CT vigilance units. In addition to the management of adverse events, the units must review the literature to identify information that may impact t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6568de4cae838104db9ebc336171e312
https://hal.science/hal-04061230/document
https://hal.science/hal-04061230/document
Autor:
Thavarak Ouk, Aurélie Jamet, Emanuela Leone, Sophie Duranton, Charlotte Muller, Marie-Paule Franceschi, Sabrina Crépin, Claire Villeneuve, Marylaure Gavard, Nadine Petitpain, Pascale Olivier, Sophie Ruault
Publikováno v:
Therapie. 76(6)
Summary Purpose To follow the European Directive 2001/20/EC, institutional sponsors created or reinforced their vigilance units. Since 2007, the working group “REflexion sur la VIgilance et la Securite des Essais” (REVISE) rallies French institut
Autor:
Emile Simon, Pierre Ingrand, Geraldine Durand, Isabelle Durand-Zaleski, Bakari Diallo, Jimmy Voirin, Benoit Bataille, Amine Ounajim, Patrick Mertens, Nicolas Naiditch, Kevin Nivole, Myriam Cadenne, Denys Fontaine, Julie Bulsei, Danièle Ranoux, Evelyne Emery, Philippe Rigoard, Guillaume Béraud, Serge Blond, Marie-Christine Djian, Philippe Page, O. Monlezun, Michel Lanteri-Minet, N. Buisset, Emmanuel Cuny, Manuel Roulaud, Françoise Debiais, Sophie Duranton, Phong Dam Hieu, François Caire, Sylvie Raoul, Philippe Peruzzi, Alain Serrie, Maxime Billot, Hussein Naous
Publikováno v:
Neuromodulation
Neuromodulation, 2021, 24 (1), pp.86-101. ⟨10.1111/ner.13251⟩
Neuromodulation, 2021, 24 (1), pp.86-101. ⟨10.1111/ner.13251⟩
BACKGROUND: Recent studies have highlighted multicolumn spinal cord stimulation (SCS) efficacy, hypothesizing that optimized spatial neural targeting provided by new-generation SCS lead design or its multicolumn programming abilities could represent
Autor:
Caroline Roussillon, Francesco Salvo, Barbara Lortal, Laura Hamy, Emilie Toulza, Anne-Laurène Colin, Sophie Duranton, Nadine Petitpain, Anne Gimbert, Pascale Olivier, Jean-Louis Montastruc, Christelle Perez, Sabrina Crépin, Madlyne Becker
Publikováno v:
Pharmacological Research
Pharmacological Research, Elsevier, 2018, 131, pp.218-223. ⟨10.1016/j.phrs.2018.02.010⟩
Pharmacological Research, Elsevier, 2018, 131, pp.218-223. ⟨10.1016/j.phrs.2018.02.010⟩
One of the main goals of safety management in clinical trials is to detect suspected unexpected serious adverse reactions (SUSARs). The unexpectedness concerns the nature, frequency or severity of an adverse reaction. Drug safety signals could thus b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c94f14df16b28e922a437064eb03a3c6
http://hdl.handle.net/20.500.12278/21441
http://hdl.handle.net/20.500.12278/21441